MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    1H-NMR and UPLC/MS Metabolomics Identify Disrupted Homeostasis of Energy, Amino Acids, and Glutathione Metabolism as Serum Signatures in Parkinson’s Disease Patients

    A. Imarisio, J. Gervasoni, C. Marino, L. Santucci, E. Napolitano, T. Nuzzo, I. Yahyavi, M. Avenali, M. Cicchinelli, C. Galandra, M. Picascia, M. Grimaldi, C. Pacchetti, F. Errico, AM. D'Ursi, A. Urbani, A. Usiello, EM. Valente (Rome, Italy)

    Objective: We sought to identify a signature distinctive of Parkinson’s disease (PD) through two independent metabolomics approaches. Background: A recent meta-analysis showed a considerable inconsistency…
  • 2025 International Congress

    Stratification study of alpha-synucleinopathy by body fluid biomarkers

    R. Kamo, A. Okuzumi, M. Iseki, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: This study aims to stratify patients with Parkinson's disease (PD) based on clinical features and several disease-associated biomarkers by analyzing the relationship between biomarkers,…
  • 2025 International Congress

    Determinants of Cognitive Progression in Parkinson’s Disease: A Machine Learning Approach

    AJ. Hernández-Medrano, A. Cervantes-Arriaga, MF. Medina-Pérez, D. Ulloa-Hernández, MF. Velasco-Delgado, GA. Martin-Mafud, AE. López-Lobato, D. Náfate-Wences, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To identify clinical and sociodemographic factors associated with cognitive decline (CD) in PD using a Random Forests model, classifying people with PD (PwP) into…
  • 2025 International Congress

    Characteristics of apathy in clinical forms of Parkinson’s disease

    O. Naimov, R. Matmurodov, S. Jumanazarova, B. Muminov (Tashkent, Uzbekistan)

    Objective: To study the severity of PD in clinical forms. Background: Apathy is one of the most common symptoms in Parkinson's disease (PD), which can…
  • 2025 International Congress

    Deep Brain Stimulation Increases Motivation to Obtain Larger Rewards in Parkinson’s Disease

    S. Brener, E. Pegolo, A. Hahn, J. Suh, M. Scherbakova, K. Balagula, P. Lockwood, M. Apps, S. Little (Birmingham, United Kingdom)

    Objective: To assess the effects of deep brain stimulation (DBS) on effort and reward processing for self-benefitting and prosocial behavior in people with Parkinson’s Disease…
  • 2025 International Congress

    Comparison of 3 Tests for Subjective Cognitive Complaints in Early Parkinson’s Disease

    R. Hoe, S. Ng, R. Chen, X. Choi, D. Heng, S. Neo, K. Tay, W. Au, E. Tan, L. Tan, Z. Xu (Singapore, Singapore)

    Objective: ​​​​​To compare 3 scales which have been used in literature to determine subjective cognitive complaints (SCC) in Parkinson’s disease (PD) and explore their relationship…
  • 2025 International Congress

    Pilot Feasibility Data using Augmented Reality and Machine Learning-Based Digital Cognitive Assessment in Parkinson’s disease

    K. Poplawska-Domaszewicz, A. Brek, K. Wu, N. Griffin, S. Fallone, M. Iulita, E. Streel, A. Kurta-Nowicka, K. Naskret-Gasik, J. Konczak, K. Ray Chaudhuri (Poznan, Poland)

    Objective: To assess the feasibility of using a novel cognitive and functional digital biomarker  assessment, the Altoida NeuroMarker platform, to evaluate the presence of MCI…
  • 2025 International Congress

    Quality of Life and Depression in Patients with and without Idiopathic Parkinson’s Disease without Dementia.

    S. Ospina Otalvaro, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, P. Andrea Gutiérrez-Leni, A. Lucumi-Moreno, S. Cárdenas-Zuñiga, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, J. Marmolejo-Florez (Cali, Colombia)

    Objective: To identify the impact of depression on QoL in a group of patients with IPDWD. Background: The Quality of Life (QoL) in patients with…
  • 2025 International Congress

    Life Course Sleep Duration Trajectories and Risk and Age at Onset of Parkinson’s Disease

    Y. Fang, R. Hardy, K. Yaffe, S. Little, C. Tanner, Y. Leng (San Francisco, USA)

    Objective: To characterize life course sleep duration trajectories and examine their associations with PD risk and age at onset (AAO). Background: Sleep disturbances could be…
  • 2025 International Congress

    Subthalamic versus Pallidal Temporal Interference Stimulation in Parkinson’s Disease: A Pilot Study

    J. Li, A. Li, C. Zhang (Shanghai, China)

    Objective: To investigate whether transcranial temporal interference stimulation (tTIS) targeting different deep brain regions produces symptom-specific improvements consistent with established deep brain stimulation (DBS) outcomes…
  • « Previous Page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley